Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 22,337 shares at $5.61 ($125,404)
  9. 4 Open-market buy Director bought 45,000 shares at $5.64 ($253,868)
  10. 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 61,266 shares (grant or award)
  11. 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 39,855 shares (grant or award)
  12. 4 Planned sale CEO sold 77,824 shares at $9.42 ($732,884)
  13. 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 20,327 shares at $9.42 ($191,425)
  14. 4 Planned sale EVP, CBO AND CTO sold 103 shares at $10.90 ($1,122)
  15. 4 Planned sale EVP, CBO AND CTO sold 695 shares at $8.21 ($5,706)
  16. 4 Planned sale EVP, CBO AND CTO sold 139 shares at $8.40 ($1,168)
  17. 4 Planned sale EVP, CBO AND CTO sold 103 shares at $8.82 ($908)
  18. 4 Planned sale EVP, CBO AND CTO sold 702 shares at $8.59 ($6,033)
  19. 4 Planned sale EVP, CBO AND CTO sold 141 shares at $8.39 ($1,183)
  20. 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 45,167 shares (grant or award)

Page 4 of 18 · 351 filings